Chescapmanager LLC Cara Therapeutics, Inc. Transaction History

Chescapmanager LLC

$913 Million
Q3 2024

A detailed history of Chescapmanager LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Chescapmanager LLC holds 1,702,110 shares of CARA stock, worth $782,970. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,702,110

Previous 1,702,110 -0.0%

Holding current value

$782,970

Previous $442,000 19.23%

% of portfolio

0.06%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.52 - $1.05 $26,001 - $52,502	-50,002 Reduced 2.85%	1,702,110 $1.55 Million
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $57,921 - $159,284	96,536 Added 5.83%	1,752,112 $1.3 Million
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $1.4 Million - $2.45 Million	495,184 Added 42.67%	1,655,576 $4.69 Million
Q2 2022 Aug 12, 2022	SELL	$7.45 - $13.84 $111,750 - $207,600	-15,000 Reduced 1.28%	1,160,392 $10.6 Million
Q1 2022 May 13, 2022	SELL	$9.94 - $12.65 $1.29 Million - $1.64 Million	-129,511 Reduced 9.92%	1,175,392 $14.3 Million
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $3,465 - $4,818	300 Added 0.02%	1,304,903 $20.2 Million
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $123,800 - $291,900	-10,000 Reduced 0.76%	1,304,603 $18.6 Million
Q4 2020 Feb 12, 2021	BUY	$12.72 - $16.16 $3,816 - $4,848	300 Added 0.02%	1,314,603 $19.9 Million
Q3 2020 Nov 16, 2020	SELL	$12.34 - $17.92 $2.1 Million - $3.05 Million	-170,000 Reduced 11.45%	1,314,303 $16.7 Million
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $2.22 Million - $3.1 Million	178,894 Added 13.7%	1,484,303 $25.4 Million
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $52,056 - $101,488	5,708 Added 0.44%	1,305,409 $17.2 Million
Q4 2019 Feb 12, 2020	BUY	$16.11 - $25.98 $926,325 - $1.49 Million	57,500 Added 4.63%	1,299,701 $20.9 Million
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $2.56 Million - $3.77 Million	140,000 Added 12.7%	1,242,201 $22.7 Million
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $1.78 Million - $2.18 Million	-100,854 Reduced 8.38%	1,102,201 $23.7 Million
Q1 2019 May 15, 2019	SELL	$14.41 - $19.64 $23,041 - $31,404	-1,599 Reduced 0.13%	1,203,055 $23.6 Million
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $706,718 - $963,340	40,223 Added 3.45%	1,204,654 $28.9 Million
Q2 2018 Aug 10, 2018	BUY	$11.6 - $19.27 $1.29 Million - $2.15 Million	111,498 Added 10.59%	1,164,431 $22.3 Million
Q1 2018 May 14, 2018	BUY	$11.77 - $16.08 $235,400 - $321,599	20,000 Added 1.94%	1,052,933 $13 Million
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $119,109 - $141,405	10,043 Added 0.98%	1,032,933 $12.6 Million
Q3 2017 Nov 13, 2017	BUY	$12.6 - $16.34 $56,700 - $73,530	4,500 Added 0.44%	1,022,890 $14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,018,390	1,018,390 $15.7 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $24.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chescapmanager LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chescapmanager LLC with notifications on news.

Account

Chescapmanager LLC Cara Therapeutics, Inc. Transaction History